Cargando…
Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis
INTRODUCTION: We hypothesized that children with Down syndrome who were born after the implementation of first‐trimester combined screening for trisomy 13, 18, and 21 and a second‐trimester ultrasound scan in Denmark would show a milder syndrome phenotype. We investigated the birth biometry, prevale...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201969/ https://www.ncbi.nlm.nih.gov/pubmed/37186080 http://dx.doi.org/10.1111/aogs.14573 |
_version_ | 1785045352801370112 |
---|---|
author | Steffensen, Ellen Hollands Pedersen, Lars Henning Lou, Stina Vogel, Ida |
author_facet | Steffensen, Ellen Hollands Pedersen, Lars Henning Lou, Stina Vogel, Ida |
author_sort | Steffensen, Ellen Hollands |
collection | PubMed |
description | INTRODUCTION: We hypothesized that children with Down syndrome who were born after the implementation of first‐trimester combined screening for trisomy 13, 18, and 21 and a second‐trimester ultrasound scan in Denmark would show a milder syndrome phenotype. We investigated the birth biometry, prevalence of congenital malformations, and early childhood morbidity of children with Down syndrome before and after implementation of this screening program. MATERIAL AND METHODS: A nationwide register‐based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biometry, prevalence of congenital malformations, and early childhood morbidity related to the implementation of a national prenatal screening program. RESULTS: We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z‐scores of birthweight and head circumference increased over time before screening, but this temporal development changed after implementation by −0.05 (95% confidence interval [CI]: −0.11 to 0.01) and −0.05 (95% CI −0.12 to 0.02), respectively. Just after implementation, the prevalence of non‐severe congenital heart disease decreased (relative change in odds 0.48 [95% CI: 0.24–0.94]). For severe congenital heart disease, atrioventricular septal defect, and non‐heart malformations, this change was 1.16 (95% CI: 0.56–2.41), 0.95 (95% CI: 0.43–2.03), and 0.98 (95% CI: 0.33–2.76), respectively. For all malformations, pre‐existing temporal developments did not change following implementation of screening. The implementation was associated with higher odds of admission to a neonatal intensive care unit (relative change 1.98 [95% CI: 0.76–5.26]) and an increased risk of hearing impairment (risk difference 3.4% [95% CI: −0.4% to 7.1%]). In contrast, the implementation was not associated with the incidence of hospital admissions by 2 years of age or with the probability of a thyroid disorder. CONCLUSIONS: After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non‐severe congenital heart disease; this result is, however, limited by small numbers. |
format | Online Article Text |
id | pubmed-10201969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102019692023-05-23 Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis Steffensen, Ellen Hollands Pedersen, Lars Henning Lou, Stina Vogel, Ida Acta Obstet Gynecol Scand Fetal Medicine INTRODUCTION: We hypothesized that children with Down syndrome who were born after the implementation of first‐trimester combined screening for trisomy 13, 18, and 21 and a second‐trimester ultrasound scan in Denmark would show a milder syndrome phenotype. We investigated the birth biometry, prevalence of congenital malformations, and early childhood morbidity of children with Down syndrome before and after implementation of this screening program. MATERIAL AND METHODS: A nationwide register‐based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biometry, prevalence of congenital malformations, and early childhood morbidity related to the implementation of a national prenatal screening program. RESULTS: We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z‐scores of birthweight and head circumference increased over time before screening, but this temporal development changed after implementation by −0.05 (95% confidence interval [CI]: −0.11 to 0.01) and −0.05 (95% CI −0.12 to 0.02), respectively. Just after implementation, the prevalence of non‐severe congenital heart disease decreased (relative change in odds 0.48 [95% CI: 0.24–0.94]). For severe congenital heart disease, atrioventricular septal defect, and non‐heart malformations, this change was 1.16 (95% CI: 0.56–2.41), 0.95 (95% CI: 0.43–2.03), and 0.98 (95% CI: 0.33–2.76), respectively. For all malformations, pre‐existing temporal developments did not change following implementation of screening. The implementation was associated with higher odds of admission to a neonatal intensive care unit (relative change 1.98 [95% CI: 0.76–5.26]) and an increased risk of hearing impairment (risk difference 3.4% [95% CI: −0.4% to 7.1%]). In contrast, the implementation was not associated with the incidence of hospital admissions by 2 years of age or with the probability of a thyroid disorder. CONCLUSIONS: After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non‐severe congenital heart disease; this result is, however, limited by small numbers. John Wiley and Sons Inc. 2023-04-25 /pmc/articles/PMC10201969/ /pubmed/37186080 http://dx.doi.org/10.1111/aogs.14573 Text en © 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Fetal Medicine Steffensen, Ellen Hollands Pedersen, Lars Henning Lou, Stina Vogel, Ida Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis |
title | Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis |
title_full | Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis |
title_fullStr | Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis |
title_full_unstemmed | Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis |
title_short | Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis |
title_sort | impact of a prenatal screening program on the down syndrome phenotype: an interrupted time series analysis |
topic | Fetal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201969/ https://www.ncbi.nlm.nih.gov/pubmed/37186080 http://dx.doi.org/10.1111/aogs.14573 |
work_keys_str_mv | AT steffensenellenhollands impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis AT pedersenlarshenning impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis AT loustina impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis AT vogelida impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis AT impactofaprenatalscreeningprogramonthedownsyndromephenotypeaninterruptedtimeseriesanalysis |